Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ) has issued an update.
Dr. Reddy’s Laboratories has notified stock exchanges that the audio recording of its earnings call for the quarter ended December 31, 2025, held on January 21, 2026, has been made publicly available via a web link on the company’s website. The disclosure, made under Indian listing regulations, enhances transparency for investors and other stakeholders by providing direct access to management’s commentary on quarterly performance and outlook, reinforcing the company’s adherence to corporate governance and disclosure norms.
More about Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacture and marketing of a wide range of generic and branded medicines as well as active pharmaceutical ingredients, with listings on Indian exchanges and the New York Stock Exchange.
Average Trading Volume: 81,308
Technical Sentiment Signal: Hold
Current Market Cap: 973.1B INR
For an in-depth examination of DRREDDY stock, go to TipRanks’ Overview page.